SEC Form SCHEDULE 13G filed by Lionsgate Studios Corp
SCHEDULE 13G - Lionsgate Studios Corp. (0002052959) (Subject)
- Executive Vice President Shine Sarah acquired $1,958 worth of shares (9 units at $218.93), increasing direct ownership by 2% to 547 units (SEC Form 4)
4 - ERIE INDEMNITY CO (0000922621) (Issuer)
- SEC Form 4 filed by EVP Chief Tech&Global New Prod Linares Carlos G.
4 - CHURCH & DWIGHT CO INC /DE/ (0000313927) (Issuer)
- EVP & CFO Pelkowski Julie Marie acquired $1,699 worth of shares (8 units at $218.93), increasing direct ownership by 1% to 671 units (SEC Form 4)
4 - ERIE INDEMNITY CO (0000922621) (Issuer)
- SEC Form 4 filed by President and CEO Dierker Richard A
4 - CHURCH & DWIGHT CO INC /DE/ (0000313927) (Issuer)
- SEC Form RW filed by Apex Global Brands Inc.
RW - APEX Global Solutions Ltd (0002069858) (Filer)
- SEC Form APP NTC filed by PCM Fund Inc.
APP NTC - PCM FUND, INC. (0000908187) (Filer)
- SEC Form 144 filed by Slide Insurance Holdings Inc.
144 - Slide Insurance Holdings, Inc. (0001886428) (Subject)
- USCB Financial Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
8-K - USCB FINANCIAL HOLDINGS, INC. (0001901637) (Filer)
- Senior Vice President, Life Dabreo Anthony acquired $2,080 worth of shares (10 units at $218.93), increasing direct ownership by 0.70% to 1,374 units (SEC Form 4)
4 - ERIE INDEMNITY CO (0000922621) (Issuer)
- SEC Form 4 filed by EVP of Strategy, M&A, and BP Buchert Brian D
4 - CHURCH & DWIGHT CO INC /DE/ (0000313927) (Issuer)
- Executive Vice President Cook Cody acquired $2,077 worth of shares (9 units at $218.93), increasing direct ownership by 0.84% to 1,136 units (SEC Form 4)
4 - ERIE INDEMNITY CO (0000922621) (Issuer)
- SEC Form SD filed by Cooper-Standard Holdings Inc.
SD - Cooper-Standard Holdings Inc. (0001320461) (Filer)
- SEC Form APP NTC filed by Guggenheim Strategic Opportunities Fund
APP NTC - GUGGENHEIM STRATEGIC OPPORTUNITIES FUND (0001380936) (Filer)
- Amendment: SEC Form SCHEDULE 13G/A filed by UBS Group AG Registered
SCHEDULE 13G/A - UBS Group AG (0001610520) (Filed by)
- Esperion Therapeutics downgraded by H.C. Wainwright
H.C. Wainwright downgraded Esperion Therapeutics from Buy to Neutral
- SEC Form 424B3 filed by Rubico Inc.
424B3 - Rubico Inc. (0001943421) (Filer)
- SEC Form DEF 14A filed by WidePoint Corporation
DEF 14A - WIDEPOINT CORP (0001034760) (Filer)